1,158.60
Netflix Inc stock is traded at $1,158.60, with a volume of 3.78M.
It is down -0.07% in the last 24 hours and down -10.44% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$1,159.40
Open:
$1163.01
24h Volume:
3.78M
Relative Volume:
1.11
Market Cap:
$492.32B
Revenue:
$41.69B
Net Income/Loss:
$10.25B
P/E Ratio:
49.37
EPS:
23.47
Net Cash Flow:
$8.50B
1W Performance:
-1.85%
1M Performance:
-10.44%
6M Performance:
+18.62%
1Y Performance:
+85.42%
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NFLX
Netflix Inc
|
1,158.60 | 492.66B | 41.69B | 10.25B | 8.50B | 23.47 |
![]()
DIS
Walt Disney Co
|
116.59 | 214.13B | 94.04B | 8.91B | 10.90B | 4.89 |
![]()
LYV
Live Nation Entertainment Inc
|
146.14 | 34.23B | 22.74B | 973.97M | 1.34B | 2.93 |
![]()
WBD
Warner Bros Discovery Inc
|
12.87 | 32.58B | 38.34B | -10.80B | 4.34B | -4.40 |
![]()
FWONK
Liberty Media Corp
|
98.94 | 25.03B | 3.51B | -102.00M | 737.00M | -0.42 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-10-25 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-07-25 | Downgrade | Seaport Research Partners | Buy → Neutral |
Jul-02-25 | Reiterated | Canaccord Genuity | Buy |
Jul-02-25 | Reiterated | Goldman | Neutral |
Jun-20-25 | Reiterated | Pivotal Research Group | Buy |
Jun-12-25 | Reiterated | Oppenheimer | Outperform |
Jun-03-25 | Reiterated | Jefferies | Buy |
May-30-25 | Reiterated | BofA Securities | Buy |
May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
Apr-21-25 | Reiterated | Barclays | Equal Weight |
Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
Apr-21-25 | Reiterated | Guggenheim | Buy |
Apr-21-25 | Reiterated | JP Morgan | Overweight |
Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
Apr-21-25 | Reiterated | MoffettNathanson | Buy |
Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
Apr-21-25 | Reiterated | Oppenheimer | Outperform |
Apr-21-25 | Reiterated | Piper Sandler | Overweight |
Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
Apr-21-25 | Reiterated | Wells Fargo | Overweight |
Apr-17-25 | Resumed | Piper Sandler | Overweight |
Mar-27-25 | Initiated | FBN Securities | Outperform |
Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
Jan-22-25 | Reiterated | Oppenheimer | Outperform |
Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
Jan-15-25 | Reiterated | Oppenheimer | Outperform |
Jan-08-25 | Reiterated | Goldman | Neutral |
Jan-06-25 | Reiterated | Argus | Buy |
Jan-03-25 | Reiterated | The Benchmark Company | Sell |
Dec-19-24 | Reiterated | UBS | Buy |
Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
Dec-16-24 | Reiterated | Oppenheimer | Outperform |
Dec-11-24 | Reiterated | JP Morgan | Overweight |
Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
Oct-18-24 | Reiterated | Needham | Buy |
Oct-18-24 | Reiterated | Oppenheimer | Outperform |
Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
Oct-16-24 | Reiterated | Loop Capital | Buy |
Oct-11-24 | Reiterated | Guggenheim | Buy |
Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
Oct-10-24 | Reiterated | Oppenheimer | Outperform |
Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Sep-05-24 | Initiated | China Renaissance | Hold |
Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
Jul-17-24 | Reiterated | Guggenheim | Buy |
Jul-16-24 | Reiterated | The Benchmark Company | Sell |
Jul-15-24 | Reiterated | BofA Securities | Buy |
Jul-12-24 | Reiterated | JP Morgan | Overweight |
Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-09-24 | Reiterated | TD Cowen | Buy |
Jul-02-24 | Reiterated | Argus | Buy |
May-28-24 | Reiterated | Evercore ISI | Outperform |
Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
Apr-19-24 | Upgrade | Needham | Hold → Buy |
Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
Apr-15-24 | Reiterated | Deutsche Bank | Hold |
Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
Apr-12-24 | Reiterated | Piper Sandler | Neutral |
Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
Mar-25-24 | Reiterated | Citigroup | Neutral |
Mar-12-24 | Reiterated | Jefferies | Buy |
Mar-11-24 | Reiterated | Oppenheimer | Outperform |
Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
Jan-24-24 | Reiterated | BofA Securities | Buy |
Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
Jan-24-24 | Reiterated | Evercore ISI | Outperform |
Jan-24-24 | Reiterated | Goldman | Neutral |
Jan-24-24 | Reiterated | Guggenheim | Buy |
Jan-24-24 | Reiterated | JP Morgan | Overweight |
Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
Jan-24-24 | Reiterated | Oppenheimer | Outperform |
Jan-24-24 | Reiterated | Piper Sandler | Neutral |
Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
Jan-24-24 | Reiterated | TD Cowen | Outperform |
Jan-24-24 | Reiterated | UBS | Buy |
Jan-24-24 | Reiterated | Wells Fargo | Overweight |
Sep-18-23 | Reiterated | Evercore ISI | Outperform |
Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jul-17-23 | Reiterated | Deutsche Bank | Buy |
Jul-13-23 | Reiterated | JP Morgan | Overweight |
Jul-12-23 | Reiterated | UBS | Buy |
Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
Jun-29-23 | Reiterated | Citigroup | Buy |
Jun-28-23 | Reiterated | Oppenheimer | Outperform |
Jun-13-23 | Reiterated | BofA Securities | Buy |
Jun-13-23 | Reiterated | Guggenheim | Buy |
Apr-19-23 | Reiterated | Deutsche Bank | Buy |
Apr-19-23 | Reiterated | JP Morgan | Overweight |
Apr-19-23 | Reiterated | Jefferies | Buy |
Apr-19-23 | Reiterated | Piper Sandler | Neutral |
Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
Apr-19-23 | Reiterated | Rosenblatt | Neutral |
Apr-19-23 | Upgrade | UBS | Neutral → Buy |
Apr-11-23 | Resumed | Robert W. Baird | Neutral |
Jan-23-23 | Reiterated | Argus | Buy |
Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
Jan-20-23 | Reiterated | Deutsche Bank | Buy |
Jan-20-23 | Reiterated | Evercore ISI | Outperform |
Jan-20-23 | Reiterated | Goldman | Sell |
Jan-20-23 | Reiterated | Guggenheim | Buy |
Jan-20-23 | Reiterated | Jefferies | Buy |
Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
Jan-20-23 | Reiterated | Oppenheimer | Outperform |
Jan-20-23 | Reiterated | Piper Sandler | Neutral |
Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
Jan-20-23 | Reiterated | The Benchmark Company | Sell |
Jan-20-23 | Reiterated | Wedbush | Outperform |
Jan-20-23 | Reiterated | Wolfe Research | Outperform |
Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
Jan-04-23 | Initiated | New Street | Neutral |
Dec-29-22 | Upgrade | CFRA | Sell → Buy |
Dec-14-22 | Reiterated | Jefferies | Hold |
Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-20-22 | Upgrade | Needham | Underperform → Hold |
Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
Apr-20-22 | Downgrade | Stifel | Buy → Hold |
Apr-20-22 | Downgrade | UBS | Buy → Neutral |
Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Apr-19-22 | Initiated | Rosenblatt | Neutral |
Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
Jan-21-22 | Reiterated | BofA Securities | Buy |
Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
Jan-21-22 | Reiterated | Cowen | Outperform |
Jan-21-22 | Reiterated | Deutsche Bank | Hold |
Jan-21-22 | Reiterated | Goldman | Neutral |
Jan-21-22 | Reiterated | Guggenheim | Buy |
Jan-21-22 | Reiterated | JP Morgan | Overweight |
Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jan-21-22 | Reiterated | Oppenheimer | Outperform |
Jan-21-22 | Reiterated | Piper Sandler | Overweight |
Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-21-22 | Reiterated | Stifel | Buy |
Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
Jan-21-22 | Downgrade | Truist | Buy → Hold |
Jan-21-22 | Reiterated | UBS | Buy |
Jan-21-22 | Reiterated | Wolfe Research | Outperform |
Dec-15-21 | Reiterated | The Benchmark Company | Sell |
Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Sep-29-21 | Reiterated | The Benchmark Company | Sell |
Sep-13-21 | Initiated | Goldman | Neutral |
Sep-08-21 | Reiterated | JP Morgan | Overweight |
Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
Jul-21-21 | Reiterated | Credit Suisse | Outperform |
Jul-21-21 | Reiterated | Deutsche Bank | Buy |
Jul-21-21 | Reiterated | JP Morgan | Overweight |
Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-21-21 | Reiterated | Stifel | Buy |
Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-25-21 | Initiated | Edward Jones | Hold |
May-19-21 | Resumed | Jefferies | Buy |
Apr-21-21 | Resumed | Oppenheimer | Outperform |
Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
Apr-21-21 | Upgrade | Stifel | Hold → Buy |
Apr-06-21 | Resumed | Evercore ISI | Outperform |
Apr-01-21 | Initiated | Piper Sandler | Overweight |
Mar-25-21 | Reiterated | The Benchmark Company | Sell |
Mar-23-21 | Upgrade | Argus | Hold → Buy |
Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
Jan-20-21 | Reiterated | The Benchmark Company | Sell |
Jan-20-21 | Upgrade | UBS | Neutral → Buy |
Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
Oct-21-20 | Reiterated | Bernstein | Outperform |
Oct-21-20 | Reiterated | Jefferies | Buy |
Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
Oct-21-20 | Reiterated | Oppenheimer | Outperform |
Oct-21-20 | Reiterated | Piper Sandler | Overweight |
Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
Oct-21-20 | Reiterated | The Benchmark Company | Sell |
Oct-21-20 | Reiterated | Wedbush | Underperform |
Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
Oct-14-20 | Reiterated | Goldman | Buy |
Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
Sep-28-20 | Reiterated | The Benchmark Company | Sell |
Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-09-20 | Resumed | Raymond James | Mkt Perform |
Sep-04-20 | Reiterated | The Benchmark Company | Sell |
Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
341 Shares in Netflix, Inc. (NASDAQ:NFLX) Bought by Wooster Corthell Wealth Management Inc. - MarketBeat
Netflix Cancels Arnold Schwarzenegger’s ‘Fubar’ After Two Seasons - IMDb
Unspeakable Sins Netflix Telenovela Series: Cast, Trailer, Plot - IMDb
Meghan Markle and Prince Harry's Netflix Projects Explained - Us Weekly
The 7 Best Hidden Gems on Netflix in August - IMDb
New on Netflix: Full List of Movies, Shows Hitting the Streaming Platform in August 2025 - Newsweek
Everything New on Netflix in August 2025 - IMDb
You Know FOMO. But This Fear Might Be Costing You More. - Benzinga
Who’s In The ‘Perfect Match’ Season 3 Cast? Meet The 22 Singles Looking For Love - Forbes
Netflix’s Untitled Newfoundland Limited Series Adds Kaleb Horn, Ruby Stokes & Willow Kean As Production Begins - Deadline
UNIVEST FINANCIAL Corp Grows Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
JBF Capital Inc. Buys 2,900 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix, Inc. (NASDAQ:NFLX) Shares Acquired by Commerce Bank - MarketBeat
Netflix Sets 'Nouvelle Vague' Awards Season Release Dates & Categories - The Hollywood Reporter
What Aiming To Be The Next Disney Could Mean For Netflix Stock - Investor's Business Daily
Hopwood Financial Services Inc. Purchases 386 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
US Bancorp DE Decreases Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix, Inc. (NASDAQ:NFLX) Shares Sold by Alberta Investment Management Corp - MarketBeat
Jim Cramer on Netflix: "It’s Going To Be Fine" - Yahoo Finance
Jim Cramer on Netflix: “It’s Going To Be Fine” - Yahoo.co
Meeder Advisory Services Inc. Has $9.79 Million Stock Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Meeder Asset Management Inc. Grows Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix’s Corporate Culture Under The Microscope Again In Latest Misconduct & Discrimination Suits - Deadline
Former Netflix Executive Alleges Gender Bias and Sexual Harassment in Lawsuit - IMDb
Physicians Financial Services Inc. Invests $613,000 in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Here’s What’s New on Netflix in August 2025 - Time Magazine
‘Happy Gilmore 2’ Makes Massive Netflix Debut While ‘KPop Demon Hunters’ Breaks All the Streaming Rules | Chart - IMDb
Netflix’s ‘3 Body Problem’ Adds ‘Game of Thrones’ Alum to Season 2 Cast (Exclusive) - IMDb
Netflix is raising the stakes with this new wave of releases, leading up to the long-anticipated finale of 'One Hundred Years of Solitude.' - About Netflix
Netflix just made a key new hire as it doubles down on its global ad ambitions - Business Insider
Amazon invests in Fable, the company behind "Netflix of AI" streaming platformSeñal News - Senal News
‘Long Story Short’ Renewed for Season 2 at Netflix Ahead of Season 1 Release Date - IMDb
New Character Details Revealed for Netflix’s Upcoming ‘Extraction’ Series - What's on Netflix
Netflix Debuts Crime Drama ‘Death Inc.’ - Programming Insider
Rodrigo de la Serna Will Play Aníbal Gordon in a New Netflix Series - About Netflix
How ‘Kpop Demon Hunters’ Became Netflix’s ‘Frozen’ | Exclusive - IMDb
Netflix, Inc. (NASDAQ:NFLX) Shares Sold by EFG Asset Management Americas Corp. - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Raises Stock Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Wall Street Analysts Look Bullish on Netflix (NFLX): Should You Buy? - Yahoo Finance
MGO One Seven LLC Increases Stock Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Lyell Wealth Management LP Has $14.69 Million Stake in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Menard Financial Group LLC Increases Stock Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
TradeLink Capital LLC Buys Shares of 900 Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
First National Trust Co Buys 288 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix (NASDAQ: NFLX) Stock Price Prediction and Forecast 2025-2030 (July 2025) - 24/7 Wall St.
Netflix’s ‘The Hunting Wives’ Is a Perfect High-Summer TV Bender - GQ
Netflix Reveals 10-Title Colombia Slate Featuring True Crime, Franchise Finales and Political Drama - IMDb
Netflix Ratchets Up Colombian Production With 10 Upcoming Titles (Exclusive) - IMDb
Netflix Ratchets Up Colombian Production With 10 Upcoming Titles (EXCLUSIVE) - Variety
Lazard Freres Gestion S.A.S. Has $3.54 Million Stock Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Death Inc. on Netflix: A Satirical Autopsy of Modern Life - Martin Cid Magazine
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):